Related Experiment Video
Updated: Jun 24, 2026

10:28
Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
Single-cell profiling reveals the origin of phenotypic variability in adipogenesis
1Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America.
Plos One
|April 10, 2009
Summary
Phenotypic heterogeneity in fat cell differentiation arises not from gene expression but from variations in insulin signaling pathways. Understanding these non-mutative causes is key to controlling adipogenesis.
Area of Science:
- Cell Biology
- Biochemistry
- Molecular Biology
Background:
- Phenotypic heterogeneity within clonal cell populations is common but poorly understood.
- Non-mutative factors contributing to cell variability during differentiation require investigation.
Purpose of the Study:
- To investigate non-mutative causes of phenotypic heterogeneity during 3T3-L1 cell differentiation into adipocytes.
- To elucidate the role of insulin signaling in lipid droplet formation variability.
Main Methods:
- Employed single-cell analysis using coherent anti-Stokes Raman scattering microscopy and flow cytometry.
- Simultaneously visualized adipogenic gene expression, insulin signaling, and lipid droplet accumulation.
Main Results:
- Adipogenic gene expression (PPARgamma, C/EBPalpha, aP2, LP2) occurred in all differentiating cells.
- Lipid droplet formation varied significantly, indicating gene expression alone is insufficient.
- Insulin signaling pathway kinetics (sensitivity, kinase activity, glucose import, insulin degradation) dictated lipid droplet accumulation.
- Prolonged insulin stimulation enhanced lipid droplet formation in all cells.
Conclusions:
- Cell-to-cell variability in adipogenesis stems from differences in insulin signaling cascade responses.
- The kinetics of insulin signaling, not just gene expression, drive phenotypic heterogeneity in adipogenesis.
- Single-cell profiling offers insights into the origins of variability in drug-inducible adipogenesis.

